ArticlePhysical and engineering sciences in medicine2026
Real-time ECG-based detection of cardiovascular diseases using balanced and interpretable machine learning approaches.
Article in Physical and engineering sciences in medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Cardiovascular diseases (CVDs) are still the leading cause of death worldwide, emphasizing the critical need for reliable diagnostic systems. This study aims to create a standardized electrocardiogram (ECG) dataset that can be used to detect and classify six major CVDs using machine learning techniques and investigate feature selection and extraction methods for improved performance. A large dataset of 34,580 12-lead ECG recordings was collected from Sher-i-Kashmir Institute of Medical Sciences (SKIMS), Srinagar, Jammu and Kashmir spanning six clinically confirmed classes: Normal, Cardiac Arrhythmia, Coronary Heart Disease, Cardiomyopathy, Stroke, and Heart Failure. Data pre-processing involved baseline correction, removal of artifacts and the extraction of 14 clinically informative features. To address class imbalance, the Synthetic Minority Oversampling Technique (SMOTE) was applied, resulting in an equal distribution of 16.7% of the data across each class. Ten Machine learning and deep learning models-Logistic Regression, Decision Tree, Random Forest, SVM, KNN, Naive Bayes, Gradient Boosting, MLP, DNN, and RNN-were trained and tested. SHAP and LIME methods were used for interpretability. On the raw dataset, Random Forest and Gradient Boosting produced highest performance with test accuracy of 99.88%, precision of 99.88%, recall of 99.88%, and F1-score of 99.88%. After SMOTE, DNN significantly improved (Accuracy: 97.62%, Precision: 97.66%, Recall: 97.62%, F1-score: 97.64%), while MLP obtained an F1-score of 98.49% and RNN obtained 94.76%. All models exhibited better generalization and stability after SMOTE. The balanced, heterogeneous, and clinically verified ECG dataset supported the highly accurate, interpretable, and real-time classification of CVD. SMOTE significantly improved the performance of the model, particularly for deep networks, substantiating its effectiveness in the class imbalance problem. These results place the proposed model and dataset as effective tools for clinical decision support in the diagnosis of cardiovascular disease.
Indexed as
Identifiers
41528718What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.